# Peraso Inc.: Form 10-Q for the period ended Mar 31, 2017

- Company: [Peraso Inc.](/companies/prso.md) (CIK 890394)
- Form: 10-Q
- Filed: 2017-05-12
- Accepted by EDGAR: May 12, 2017, 11:29 ET
- Period: 2017-03-31
- Accession: 0001558370-17-004246
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/890394/000155837017004246/mosy-20170331x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/890394/000155837017004246/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2017-01-01 to 2017-03-31 | $602.0k | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2017-01-01 to 2017-03-31 | $610.0k | us-gaap:GrossProfit |
| Research and development | 3 months, 2017-01-01 to 2017-03-31 | $3.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2017-01-01 to 2017-03-31 | $1.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-01-01 to 2017-03-31 | −$4.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2017-01-01 to 2017-03-31 | $224.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-01-01 to 2017-03-31 | $5.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-01-01 to 2017-03-31 | −$4.4m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Cash and equivalents | at 2017-03-31 | $5.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-03-31 | $7.7m | us-gaap:AssetsCurrent |
| Total assets | at 2017-03-31 | $22.3m | us-gaap:Assets |
| Current liabilities | at 2017-03-31 | $2.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2017-03-31 | $11.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2017-03-31 | $11.1m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 26,350 characters.

*This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the accompanying condensed consolidated financial statements and notes included in this report. This Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which include, without limitation, statements about the market for our technology, our strategy, competition, expected financial performance and capital raising efforts, all information disclosed under Item 3 of this Part I, and other aspects of our business identified in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission on March 15, 2016 and in other reports that we file from time to time with the Securities and Exchange Commission. Any statements about our business, financial results, financial condition and operations contained in this Form 10-Q that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “believes,” “anticipates,” “expects,” “intends,” “plans,” “projects,” or similar expressions are intended to identify forward-looking statements. Our actual results could differ materially from those expressed or implied by these forward-looking statements as a result of various factors, including the risk factors described below in “Company Overview,” “Liquidity and Capital Resources; Changes in Financial Condition,” “Risk Factors” and elsewhere in this report and under Item 1A of our annual report on Form 10-K for the year ended December 31, 2016. We undertake no obligation to update publicly any forward-looking statements for any reason, except as required by law, even as new information becomes available or events occur in the future.*

### Company Overview

We are a fabless semiconductor company focused on the development and sale of integrated circuits, or ICs, for the high-speed networking, communications, storage and data center markets. Our solutions deliver time-to-market, performance, power, area and economic benefits for system original equipment manufacturers, or OEMs. We have developed two families of ICs under the Bandwidth Engine® and LineSpeed™ product names. Bandwidth Engine ICs combine our proprietary 1T-SRAM® high-density embedded memory, integrated macro functions and high-speed serial interface, or SerDes, I/O, with our intelligent access technology and a highly efficient interface protocol. The LineSpeed IC product line, which was announced in March 2013, is comprised of non-memory, high-speed SerDes I/O devices with clock data recovery, gearbox and retimer functionality, which convert lanes of data received on line cards or by optical modules into different configurations and/or ensure signal integrity. Historically, our primary business was the design, development, marketing, sale and support of differentiated intellectual property, or IP, including embedded memory and high-speed parallel and SerDes I/O used in advanced systems-on-chips, or SoCs. Currently, we are focused on developing differentiated IP-rich IC products and are dedicating all our research and development, marketing and sales budget to these IC products.

Our future success and ability to achieve and maintain profitability are dependent on the marketing and sales of our IC products into networking, communications and other markets requiring high-bandwidth memory access.

We incurred a net loss of $4.4 million for the quarter ended March 31, 2017 and had an accumulated deficit of $218.4 million as of March 31, 2017. In addition, we incurred net losses of approximately $32.0 million and $31.5 million for the years ended December 31, 2016 and 2015, respectively. These and prior year losses have resulted in significant negative cash flows for almost a decade and have required us to raise substantial amounts of additional capital during this period. To date, we have primarily financed our operations through multiple offerings of common stock to investors and affiliates, as well as asset sale transactions. In March 2016, we entered into a 10% Senior Secured Convertible Note Purchase Agreement with the purchasers of $8.0 million principal amount of 10% Senior Secured Convertible Notes due August 15, 2018 (the Notes), at par, in a private placement transaction. The Notes bear interest at the annual rate of 10%. Accrued interest is payable semi-annually in cash or in-kind through the issuance of identical new Notes, or with a combination of the two, at our option. Since issuance of the Notes, we have made the interest payments in-kind through the issuance of additional notes totaling approximately $0.8 million. Further, the Notes restrict our ability to incur any indebtedness for borrowed money, unless such indebtedness by its terms is expressly subordinated to the Notes in right of payment and to the security interest of the Note holder(s) in respect to the priority and enforcement of any security interest in our property securing such new debt; provided that the Note holder(s) security interest and cash payment rights under the Notes shall be subordinate to a maximum of $5 million of indebtedness for a secured accounts receivable line of credit facility under certain conditions.

We expect to continue to incur operating losses for the foreseeable future as it secures customers for and continues to invest in the commercialization of our IC products. We will need to increase revenues substantially beyond levels that it has attained in the past in order to generate sustainable operating profit and sufficient cash flows to continue doing business without raising additional capital from time to time. As a result of our expected operating losses and cash burn for the foreseeable future, recurring losses from operations, and the need to repay the Notes and accrued interest in 2018, if we are unable to raise sufficient capital through additional debt or equity arrangements, there will be uncertainty regarding our ability to maintain liquidity sufficient to operate our business effectively, which raises substantial doubt as to our ability to continue as a going concern within one year from the date of issuance of these consolidated financial statements. These consolidated financial statements do not include any adjustments that might result from this uncertainty. There can be no assurance that such additional capital, whether in the form of debt or equity financing, will be sufficient or available and, if available, that such capital will be offered on terms and conditions acceptable to us. As further discussed in Note No. 9 to the Condensed Consolidated Financial Statements, in April 2017, we committed to effect a reduction in our workforce and associated operating expenses, net loss and cash burn as part of our efforts to sustain our business. We will primarily focus our resources on producing and selling our existing products, and will substantially curtail new product development. If we are unsuccessful in these efforts, we will need to implement additional cost reduction strategies, which could further affect our near- and long-term business plan. These efforts may include, but are not limited to, further reducing headcount and curtailing business activities.

### Sources of Revenue

*Product.* Product revenue is generally recognized at the time of shipment to our customers. An estimated allowance may be recorded, at the time of shipment, for future returns and other charges against revenue consistent with the terms of sale. IC product revenue and costs relating to sales made through distributors with rights of return and stock rotation are deferred until the distributors sell the product to end customers due to our inability to estimate future returns and credits to be issued. At the time of shipment to distributors, an account receivable for the selling price is recorded, as there is a legally enforceable right to receive payment, inventory is relieved, as legal title to the inventory is transferred upon shipment, and the associated deferred margin is recorded as deferred revenues in the condensed consolidated balance sheets. Revenues are recognized upon receiving notification from the distributors that products have been sold to end customers.

*Royalty.* Royalty revenue represents amounts earned under provisions in our memory licensing contracts that require our licensees to report royalties and make payments at a stated rate based on actual units manufactured or sold by licensees for products that include our memory IP. Our license agreements require the licensee to report the manufacture or sale of products that include our technology after the end of the quarter in which the sale or manufacture occurs, and we recognize royalties in the quarter in which we receive the licensee’s report. The timing and level of royalties are difficult to predict. They depend on the licensee’s ability to market, produce and sell products incorporating our technology.

### Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with Generally Accepted Accounting Principals (GAAP). The preparation of these financial statements requires us to make certain estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis we make these estimates based on our historical experience and on assumptions that we consider reasonable under the circumstances. Actual results may differ from these estimates, and reported results could differ under different assumptions or conditions. Our significant accounting policies and estimates are disclosed in Note 1 of the “Notes to Consolidated Financial Statements” in our Annual Report on Form 10-K for the year ended December 31, 2016. As of March 31, 2016, there have been no material changes to our significant accounting policies and estimates, except that we adopted ASU No. 2017-04, *Simplifying the Test for Goodwill Impairment,* effective January 1, 2017, as discussed in Note 1 to the Condensed Consolidated Financial Statements.

### Recent Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (FASB) issued ASU No. 2014-09 (ASU 2014-09), *Revenue from Contracts with Customers*, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods and services to customers. In March, April and May 2016, the FASB issued additional updates to the new revenue standard relating to reporting revenue on a gross versus net basis, identifying performance obligations and licensing arrangements, and narrow-scope improvements and practical expedients, respectively. ASU 2014-09 will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The accounting standard is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017. Early adoption is permitted for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2016. ASU 2014-09 provides for one of two methods of transition: retrospective application to each prior period presented; or recognition of the cumulative effect of retrospective application of the new standard in the period of initial application. We do not intend to early adopt this standard and plan to use the full retrospective approach to the transition. We do not expect that the adoption of ASU 2014-09 will have a material impact on our consolidated financial statements. However, assuming all other revenue recognition criteria have been met, it is likely that ASU 2014-09 would require us to recognize revenue and cost relating to distributor sales upon product delivery, subject to estimated allowances for distributor price adjustments and rights of return.

In February 2016, the FASB issued ASU No. 2016-02 (ASU 2016-02), *Leases.* ASU 2016-02 requires lessees to recognize a right-of-use asset and a lease liability equal to the present value of the lease payments for virtually all leases not classified as short term. Consistent with current U.S. GAAP, the recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee primarily depend on its classification as a finance or operating lease. The ASU also will require disclosures to provide additional qualitative and quantitative information about the amounts recorded in the financial statements. ASU 2016-02 is effective for annual and interim reporting periods beginning after December 15, 2018, with early adoption permitted. The new standard requires a modified retrospective transition for application at the beginning of the earliest comparative period presented. We are currently evaluating the impact that ASU 2016-02 will have on our consolidated financial statements and related disclosures.

### Results of Operations

#### Net Revenue.

*(dollar amounts in thousands)*

|  | March 31, 2017 | 2016 | Change 2016 to 2017 |  |
| --- | ---: | ---: | ---: | ---: |
| Product -three months ended | $955 | $1,120 | $(165) | (15)% |
| Percentage of total net revenue | 79% | 77% |  |  |

Product revenue decreased for the three months ended March 31, 2017 compared with the same period of 2016 primarily due to lower shipment volumes of our Bandwidth Engine products.

*(dollar amounts in thousands)*

|  | March 31, 2017 | 2016 | Change 2016 to 2017 |  |
| --- | ---: | ---: | ---: | ---: |
| Royalty | $257 | $331 | $(74) | (22)% |
| Percentage of total net revenue | 21% | 23% |  |  |

Royalty revenue includes revenues generated from licensing agreements. Royalty revenue decreased due to a decrease in shipment volumes by licensees whose products incorporate our licensed IP.

#### Cost of Net Revenue and Gross Profit.

*(dollar amounts in thousands)*

|  | March 31, 2017 | 2016 | Change 2016 to 2017 |  |
| --- | ---: | ---: | ---: | ---: |
| Cost of net revenue | $602 | $863 | $(261) | (30)% |
| Percentage of total net revenue | 50% | 59% |  |  |

*(dollar amounts in thousands)*

|  | March 31, 2017 | 2016 | Change 2016 to 2017 |  |
| --- | ---: | ---: | ---: | ---: |
| Gross profit | $610 | $588 | $22 | 4% |
| Gross margin | 50% | 41% |  |  |

Cost of net revenue is primarily comprised of direct and indirect costs related to the sale of IC products.

Cost of net revenue decreased for the three months ended March 31, 2017 compared with the same period of 2016 primarily due to reduced shipment volumes and reduced product manufacturing costs.

Gross margin increased for the three months ended March 31, 2017, compared with the same period of 2016, primarily due to the increase in gross profit from our product sales due to reduced manufacturing costs, partially offset by the decrease in royalty revenue which has no corresponding costs.

#### Research and Development.

*(dollar amounts in thousands)*

|  | March 31, 2017 | 2016 | Change 2016 to 2017 |  |
| --- | ---: | ---: | ---: | ---: |
| Research and development | $3,485 | $5,232 | (1,747) | $(33)% |
| Percentage of total net revenue | 288% | 361% |  |  |

Our research and development expenses include costs related to the development of our IC products and amortization of intangible assets. We expense research and development costs as they are incurred.

The decrease for the three months ended March 31, 2017 compared with the same period in 2016 was primarily due to reduced personnel, product development and qualification, computer-aided design software and stock-based compensation expenses.

We expect research and development expenses to decrease in 2017 as compared with 2016 due to reductions in personnel as a result of our restructuring activity in the second quarter of 2017 (discussed in Note 9 of the Notes to the Consolidated Condensed Financial Statements), as well as further reduced new product development and qualification and computer-aided design software expenses.

Research and development expenses included stock-based compensation expense of $0.2 million and $0.4 million for the three months ended March 31, 2017 and 2016, respectively.

#### Selling, General and Administrative.

*(dollar amounts in thousands)*

|  | March 31, 2017 | 2016 | Change 2016 to 2017 |  |
| --- | ---: | ---: | ---: | ---: |
| Selling, general and administrative | $1,314 | $1,516 | $(202) | (13)% |
| Percentage of total net revenue | 108% | 104% |  |  |

Selling, general and administrative, or SG&A, expenses consist primarily of personnel and related overhead costs for sales, marketing, finance, human resources and general management.

The decrease for the three months ended March 31, 2017 compared with the same period in 2016 was primarily due to lower compensation costs, including stock-based compensation charges. We expect SG&A expenses to decrease slightly in 2017, as compared with 2016, due to the effects of our restructuring activity in the second quarter of 2017, partially offset by increased commission expenses due to expected increases in product revenue.

Selling, general and administrative expenses included stock-based compensation expense of $0.1 million and $0.2 million for the three months ended March 31, 2017 and 2016, respectively.

#### Restructuring Charges.

*(dollar amounts in thousands)*

|  | Three months ended March 31, 2017 | 2016 | Year-Over-Year Change 2016 to 2017 |  |
| --- | ---: | ---: | ---: | ---: |
| Restructuring charges | $— | $676 | $(676) | (100)% |
| Percentage of total net revenue | —% | 47% |  |  |

In the first quarter of 2016, we recorded restructuring charges attributable to a reduction in force in the United States and the closure of operations at our Indian subsidiary. We expect to incur additional restructuring charges in

2017, as, in the quarter ending June 30, 2017, we committed to effect a reduction in our workforce and associated operating expenses.

#### Interest expense and other income, net

*(dollar amounts in thousands)*

|  | March 31, 2017 | 2016 | Change 2016 to 2017 |  |
| --- | ---: | ---: | ---: | ---: |
| Interest expense and other income (expense), net | $(211) | $(9) | $202 | 2,244% |
| Percentage of total net revenue | (17)% | (1)% |  |  |

Interest expense and other income (expense), net primarily consisted of interest expense on our senior secured convertible notes, partially offset by interest income on our investments, as well as foreign currency transaction activity and other non-operating items. We paid the accumulated interest for the six-month period ended February 15, 2017 in-kind through the issuance of an identical new senior secured convertible note.

#### Income Tax Provision.

*(dollar amounts in thousands)*

|  | March 31, 2017 | 2016 | Change 2016 to 2017 |  |
| --- | ---: | ---: | ---: | ---: |
| Income tax provision | $5 | $20 | $(15) | (75)% |
| Percentage of total net revenue | \< 1% | 1% |  |  |

The income tax provisions for the three months ended March 31, 2017 and 2016 were primarily attributable to taxes on earnings of our foreign subsidiaries and branches. We expect our income tax provision to decline in future periods, as we ceased operations at our Indian subsidiary in 2016. We believe that, based on the history of our operating losses and other factors, the weight of available evidence indicates that it is more likely than not that we will be unable to realize the benefit of our net operating losses, which are primarily generated in the United States. Accordingly, a full valuation reserve has been recorded against our net deferred tax assets.

### Liquidity and Capital Resources; Changes in Financial Condition

#### Cash Flows

As of March 31, 2017, we had cash, cash equivalents and short-term investments of $5.6 million and had total working capital of $5.3 million. Our primary capital requirements are to fund working capital, including development of our IC products.

Net cash used in operating activities was $4.2 million for the first three months of 2017, which primarily resulted from our net loss of $4.4 million, partially offset by non-cash charges, including stock-based compensation expense of $0.2 million and depreciation and amortization expenses of $0.2 million.

Net cash used in operating activities was $7.2 million for the first three months of 2016, which primarily resulted from our net loss of $6.9 million and $1.3 million in net reductions in assets and liabilities, partially offset by non-cash charges, including stock-based compensation expense of $0.6 million and depreciation and amortization expenses of $0.3 million. The changes in assets and liabilities primarily related to the timing of payments to vendors.

Net cash provided by investing activities was $0.8 million for the first three months of 2017, and included net amounts transferred to cash and cash equivalents from investments of $0.8 million, which did not impact our liquidity.

Net cash provided by investing activities was $4.0 million for the first three months of 2016, and included net amounts transferred to cash and cash equivalents from investments of $4.2 million, which did not impact our liquidity, partially offset by $0.2 million for purchases of fixed assets.

Net cash used in financing activities for the first three months of 2017 consisted primarily of payments of income taxes related to the issuance of common stock upon vesting of restricted stock units.

Our proceeds from financing activities for the first three months of 2016 of $8.0 million consisted primarily of net proceeds received from the issuance of senior secured convertible notes and proceeds from the purchases of common stock under our employee stock purchase plan.

Our future liquidity and capital requirements are expected to vary from quarter to quarter, depending on numerous factors, including:

- level of revenue;
- cost, timing and success of technology development efforts;
- inventory levels, timing of product shipments and length of billing and collection cycles;
- fabrication costs, including mask costs, of our ICs, currently under development;
- variations in manufacturing yields, materials costs and other manufacturing risks;
- costs of acquiring other businesses and integrating the acquired operations;
- profitability of our business; and
- whether interest payments on the Notes are paid in cash or, at our election, in kind through the issuance of new Notes with identical terms for the accrued interest.

### Going Concern - Working Capital

We expect our cash expenditures to continue to exceed receipts in 2017, as our revenues will not be sufficient to offset our operating expenses. The condensed consolidated financial statements presented in Item 1 of this Report have been prepared assuming that we will continue as a going concern, and do not include any adjustments that might result from the outcome of this uncertainty. We have incurred recurring losses from operations, had recurring negative cash flows, and have a significant accumulated deficit. These conditions raise substantial doubt about our ability to continue as a going concern. We are currently seeking additional financing in order to meet our cash requirements for the foreseeable future. We may not be able to obtain additional financing as needed on acceptable terms, or at all, which may require us to reduce our operating costs and other expenditures, including reductions of personnel, salaries and capital expenditures. As further discussed in Note No. 9 of the condensed consolidated financial statements, in April 2017, we committed to effect a reduction in our workforce and associated operating expenses, net loss and cash burn as part of our efforts to sustain our business. We will primarily focus our resources on producing and selling our existing products, and will substantially curtail new product development. If we are unsuccessful in these efforts, we will need to implement additional cost reduction strategies, which could further affect our near- and long-term business plan. These efforts may include, but are not limited to, further reducing headcount and curtailing business activities. Any such actions undertaken might limit our opportunities to realize plans for revenue growth and we might not be able to reduce our costs in amounts sufficient to achieve break-even or profitable operations.

If we were to raise additional capital through sales of our equity securities, our stockholders would suffer dilution of their equity ownership. If we engage in debt financing, we may be required to accept terms that restrict our ability to incur additional indebtedness, prohibit us from paying dividends, repurchasing our stock or making investments, and force us to maintain specified liquidity or other ratios, any of which could harm our business, operating results and financial condition. If we need additional capital and cannot raise it on acceptable terms, we may not be able to, among other things:

- develop or enhance our products;
- continue to expand our product development and sales and marketing organizations;
- acquire complementary technologies, products or businesses;
- expand operations, in the United States or internationally;
- hire, train and retain employees; or
- respond to competitive pressures or unanticipated working capital requirements.

Our failure to do any of these things could seriously harm our ability to execute our business strategy and may force us to curtail our existing operations.

### Contractual Obligations

The impact that our contractual obligations as of March 31, 2017 are expected to have on our liquidity and cash flow in future periods is as follows (in thousands):

|  | Payment Due by Period Total | Less than 1 year | 1-3 years | 3-5 years | More than 5 years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Operating leases | $2,616 | $759 | $1,536 | $321 | $— |
| Software licenses | 883 | 625 | 258 | — | — |
|  | $3,499 | $1,384 | $1,794 | $321 | $— |

As of March 31, 2017, our software licenses were primarily for computer-aided design software.

## Market risk

As filed, 1,013 characters.

Our investment portfolio consists of money market accounts, certificates of deposit, commercial paper, corporate debt, government-sponsored enterprise bonds and municipal bonds. The portfolio dollar-weighted average maturity of these investments is within 12 months. Our primary objective with this investment portfolio is to invest available cash while preserving principal and meeting liquidity needs. No single security should exceed 5% of the portfolio or $2.0 million at the time of purchase. In accordance with our investment policy, we place investments with high credit-quality issuers and limit the amount of credit exposure to any one issuer. These securities, which approximated $4.2 million as of March 31, 2017 and earned an average annual interest rate of approximately 0.5% during the first quarter of 2017, are subject to interest rate and credit risks. We do not have any investments denominated in foreign currencies, and, therefore, are not subject to foreign currency risk on such investments.

## Controls and procedures

As filed, 1,277 characters.

*Disclosure Controls and Procedures.* Our management is responsible for establishing and maintaining adequate internal control over our financial reporting. Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based on this evaluation, our management concluded that as of March 31, 2017, our disclosure controls and procedures were effective.

*Changes in Internal Control over Financial Reporting.* During the first quarter of 2017, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 443 characters.

We face many significant risks in our business, some of which are unknown to us and not presently foreseen. These risks could have a material adverse impact on our business, financial condition and results of operations in the future. We have disclosed a number of material risks under Item 1A of our annual report on Form 10-K for the year ended December 31, 2016, which we filed with the Securities and Exchange Commission on March 30, 2017.

Filed May 12, 2017.
Source: SEC EDGAR, the filing index for accession 0001558370-17-004246. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
